WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010151317) SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/151317    International Application No.:    PCT/US2010/001800
Publication Date: 29.12.2010 International Filing Date: 21.06.2010
IPC:
A01N 43/06 (2006.01), A61K 31/38 (2006.01)
Applicants: MILLENNIUM PHARMACEUTICALS, INC. [US/US]; 40 Landsdowne Street Cambridge, MA 02139 (US) (For All Designated States Except US).
BLACKBURN, Christopher [GB/US]; (US) (For US Only).
GIGSTAD, Kenneth, M. [US/US]; (US) (For US Only).
XU, He [CN/US]; (US) (For US Only)
Inventors: BLACKBURN, Christopher; (US).
GIGSTAD, Kenneth, M.; (US).
XU, He; (US)
Agent: KLUNDER, Janice, M.; Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, MA 02139 (US)
Priority Data:
61/219,103 22.06.2009 US
Title (EN) SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
(FR) ACIDES HYDROXAMIQUES SUBSTITUÉS ET LEURS UTILISATIONS
Abstract: front page image
(EN)This invention provides compounds of formula (/): wherein R1, R2, G, n, p and q have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.
(FR)Cette invention porte sur des composes de formule (/): dans laquelle R1, R2, G, n, p et q ont les valeurs telles que décrites dans la description, utiles en tant qu'inhibiteurs de HDAC6. L'invention porte également sur des compositions pharmaceutiques comprenant les composés de l'invention et sur des procédés d'utilisation des compositions dans le traitement de maladies ou troubles prolifératifs, inflammatoires, infectieux, neurologiques ou cardiovasculaires.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)